Exhibit 99.2

Unaudited Interim Condensed Consolidated Statement of Profit or Loss

for the six-month periods ended June 30, 2020 and 2019

amounts in thousands except per share amounts

	Six Months Ended June 30,
	2020			2019
	USD			USD
Research and development costs		(235	)		(626	)
General and administrative costs		(1,788	)		(2,602	)
Operating loss		(2,023	)		(3,228	)
Foreign exchange rate (loss) gain		(240	)		187
Other finance income, net		4			191
Net loss for the period		(2,259	)		(2,850	)
Net loss for the period attributable to:
Equity holders of the Parent		(2,259	)		(2,850	)
Net loss per share basic and diluted		(0.02	)		(0.03	)